|
|
Homogeneous Time-Resolved Fluorescence Quenching Assay (LANCE) for Caspase-3
Jarkko Karvinen
PerkinElmer Life Sciences/Wallac Oy, Turku, Finland
Pertti Hurskainen
PerkinElmer Life Sciences/Wallac Oy, Turku, Finland
Sujatha Gopalakrishnan
Abbott Laboratories, Pharmaceutical Products Division, Abbott Park, IL
David Burns
Abbott Laboratories, Pharmaceutical Products Division, Abbott Park, IL
Usha Warrior
Abbott Laboratories, Pharmaceutical Products Division, Abbott Park, IL
Ilkka Hemmilä
PerkinElmer Life Sciences/Wallac Oy, Turku, Finland
In addition to kinases and G protein—coupled receptors, proteases are one of the main targets in modern drug discovery. Caspases and viral proteases, for instance, are potential targets for new drugs. To satisfy the current need for fast and sensitive high-throughput screening for inhibitors, new homogeneous protease assays are needed. We used a caspase-3 assay as a model to develop a homogeneous time-resolved fluorescence quenching assay technology. The assay utilizes a peptide labeled with both a luminescent europium chelate and a quencher. Cleavage of the peptide by caspase-3 separates the quencher from the chelate and thus recovers europium fluorescence. The sensitivity of the assay was 1 pg/µl for active caspase-3 and 200 pM for the substrate. We evaluated the assay for high-throughput usage by screening 9600 small-molecule compounds. We also evaluated this format for absorption/distribution/metabolism/excretion assays with cell lysates. Additionally, the assay was compared to a commercial fluorescence caspase-3 assay.
Journal of Biomolecular Screening, Vol. 7, No. 3,
223-231 (2002)
DOI: 10.1177/108705710200700306
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
M. N. Uddin, D. Horvat, E. W. Childs, and J. B. Puschett
Marinobufagenin causes endothelial cell monolayer hyperpermeability by altering apoptotic signaling
Am J Physiol Regulatory Integrative Comp Physiol,
June 1, 2009;
296(6):
R1726 - R1734.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. N. Uddin, D. Horvat, S. S. Glaser, B. M. Mitchell, and J. B. Puschett
Examination of the Cellular Mechanisms by Which Marinobufagenin Inhibits Cytotrophoblast Function
J. Biol. Chem.,
June 27, 2008;
283(26):
17946 - 17953.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Bauer, L. K. Yu, G. D. Demetri, and J. A. Fletcher
Heat shock protein 90 inhibition in imatinib-resistant gastrointestinal stromal tumor.
Cancer Res.,
September 15, 2006;
66(18):
9153 - 9161.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. A. O'Brien, W. J. Daily, P. E. Hesselberth, R. A. Moravec, M. A. Scurria, D. H. Klaubert, R. F. Bulleit, and K. V. Wood
Homogeneous, Bioluminescent Protease Assays: Caspase-3 as a Model
J Biomol Screen,
March 1, 2005;
10(2):
137 - 148.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A. Ylikoski, A. Elomaa, P. Ollikka, H. Hakala, V.-M. Mukkala, J. Hovinen, and I. Hemmila
Homogeneous Time-Resolved Fluorescence Quenching Assay (TruPoint) for Nucleic Acid Detection
Clin. Chem.,
October 1, 2004;
50(10):
1943 - 1947.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. D. Pratt, C. A. David, C. Black-Schaefer, P. J. Dandliker, X. Xuei, U. Warrior, D. J. Burns, P. Zhong, Z. Cao, A. Y. C. Saiki, et al.
A Strategy for Discovery of Novel Broad-Spectrum Antibacterials Using a High-Throughput Streptococcus pneumoniae Transcription/Translation Screen
J Biomol Screen,
February 1, 2004;
9(1):
3 - 11.
[Abstract]
[PDF]
|
|
|
|
|
|
|
Q.-P. Qin, O. Peltola, and K. Pettersson
Time-resolved Fluorescence Resonance Energy Transfer Assay for Point-of-Care Testing of Urinary Albumin
Clin. Chem.,
July 1, 2003;
49(7):
1105 - 1113.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
